Senate Committee Explores Value-Based Drug Pricing to Help Stem Increases

Drug Industry Daily
The Senate’s health committee held its final hearing in a set of three this year on the rising costs of prescription drugs — this time exploring how value-based pricing could help make payments more efficient, although it brings its own set of challenges.

To View This Article:


Subscribe To Drug Industry Daily